• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕博利珠单抗治疗恶性胸膜间皮瘤患者时的辐射诱导远隔效应

Radiation Induced Abscopal Effect in a Patient With Malignant Pleural Mesothelioma on Pembrolizumab.

作者信息

Rittberg Rebekah, Chan Elisa, Yip Stephen, Alex Deepu, Ho Cheryl

机构信息

Medicine, University of British Columbia, Vancouver, CAN.

Medical Oncology, BC Cancer, Vancouver, CAN.

出版信息

Cureus. 2022 Feb 12;14(2):e22159. doi: 10.7759/cureus.22159. eCollection 2022 Feb.

DOI:10.7759/cureus.22159
PMID:35308690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8920754/
Abstract

Abscopal effect is a rare phenomenon in which treatment benefit from radiotherapy (RT) is seen outside the target field due to activation of the immune system inducing an anti-tumor effect. This phenomenon has been reported in cancer patients receiving immune checkpoint inhibitors (ICI). Here we report a case of presumed abscopal effect in malignant mesothelioma. The patient received second-line single-agent pembrolizumab however had disease progression after four cycles leading to palliative RT (20 Gray) to the right mainstem bronchus. Follow-up radiographic imaging confirmed benefit and pembrolizumab was continued. Follow-up computed tomography (CT) five months after RT, showed marked radiographic improvement of all measurable diseases with improvement in right-sided aerated lung volume. Because of the original disease progression on pembrolizumab, with marked improvements within and outside the RT field after RT, treatment response was presumed due to the abscopal effect.

摘要

远隔效应是一种罕见现象,即由于免疫系统激活诱导抗肿瘤效应,在放疗(RT)靶区外可见放疗带来的治疗益处。这种现象已在接受免疫检查点抑制剂(ICI)的癌症患者中报道过。在此,我们报告一例恶性间皮瘤疑似远隔效应的病例。该患者接受二线单药帕博利珠单抗治疗,但四个周期后疾病进展,遂对右主支气管进行姑息性放疗(20格雷)。随访影像学检查证实有获益,于是继续使用帕博利珠单抗。放疗五个月后的随访计算机断层扫描(CT)显示,所有可测量病灶在影像学上均有显著改善,右侧肺通气量增加。由于最初使用帕博利珠单抗时疾病进展,而放疗后放疗野内外均有显著改善,因此推测治疗反应归因于远隔效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8920754/1690c0da51dd/cureus-0014-00000022159-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8920754/c2b5eb6bcc1b/cureus-0014-00000022159-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8920754/6b77c9ea9c4e/cureus-0014-00000022159-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8920754/e3dad659c01c/cureus-0014-00000022159-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8920754/1690c0da51dd/cureus-0014-00000022159-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8920754/c2b5eb6bcc1b/cureus-0014-00000022159-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8920754/6b77c9ea9c4e/cureus-0014-00000022159-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8920754/e3dad659c01c/cureus-0014-00000022159-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56bd/8920754/1690c0da51dd/cureus-0014-00000022159-i04.jpg

相似文献

1
Radiation Induced Abscopal Effect in a Patient With Malignant Pleural Mesothelioma on Pembrolizumab.帕博利珠单抗治疗恶性胸膜间皮瘤患者时的辐射诱导远隔效应
Cureus. 2022 Feb 12;14(2):e22159. doi: 10.7759/cureus.22159. eCollection 2022 Feb.
2
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab.一名接受姑息性放疗和帕博利珠单抗治疗的恶性胸膜间皮瘤患者的远隔效应
Clin Transl Radiat Oncol. 2021 Jan 1;27:85-88. doi: 10.1016/j.ctro.2020.12.006. eCollection 2021 Mar.
3
First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma.姑息性放疗和免疫基因治疗恶性胸膜间皮瘤后首次出现远隔效应
Cureus. 2019 Feb 20;11(2):e4102. doi: 10.7759/cureus.4102.
4
Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.抗PD-1免疫检查点抑制下疾病进展的转移性癌症患者放射免疫治疗反应分析中的远隔效应
Front Pharmacol. 2019 May 14;10:511. doi: 10.3389/fphar.2019.00511. eCollection 2019.
5
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.帕博利珠单抗联合或不联合放疗治疗转移性非小细胞肺癌:两项随机试验的汇总分析。
Lancet Respir Med. 2021 May;9(5):467-475. doi: 10.1016/S2213-2600(20)30391-X. Epub 2020 Oct 20.
6
Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model.免疫检查点抑制剂增强放疗对 4T1 乳腺癌模型三阴性乳腺癌的远隔效应。
Int J Mol Sci. 2021 Sep 28;22(19):10476. doi: 10.3390/ijms221910476.
7
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report.纳武利尤单抗治疗的非小细胞肺癌患者行姑息性放疗后出现远隔效应和耐药逆转:病例报告。
Immunotherapy. 2021 Aug;13(12):971-976. doi: 10.2217/imt-2021-0039. Epub 2021 Jun 28.
8
Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia.三名接受放疗联合调制式射频透热治疗患者中的假定远隔效应
Front Oncol. 2020 Mar 10;10:254. doi: 10.3389/fonc.2020.00254. eCollection 2020.
9
Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors.抗PD1治疗转移性实体瘤患者远隔效应的分析
J Immunother. 2016 Nov/Dec;39(9):367-372. doi: 10.1097/CJI.0000000000000141.
10
Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma.大体积正电子发射断层扫描(PET)反应评估在接受高剂量派姆单抗治疗恶性间皮瘤的患者中优于传统标准。
J Nucl Med. 2021 Feb;62(2):191-194. doi: 10.2967/jnumed.120.245803. Epub 2020 Jun 12.

引用本文的文献

1
Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model.在小鼠间皮瘤模型中,分割低剂量放疗为免疫治疗准备肿瘤微环境。
Cancer Immunol Immunother. 2025 Jan 3;74(2):44. doi: 10.1007/s00262-024-03889-x.
2
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge.实体瘤骨转移的远隔效应:挑战中的挑战之系统评价与回顾性分析
Biomedicines. 2023 Apr 12;11(4):1157. doi: 10.3390/biomedicines11041157.

本文引用的文献

1
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.纳武利尤单抗对比安慰剂治疗复发恶性间皮瘤患者(CONFIRM):一项多中心、双盲、随机、III 期临床试验。
Lancet Oncol. 2021 Nov;22(11):1530-1540. doi: 10.1016/S1470-2045(21)00471-X. Epub 2021 Oct 14.
2
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab.一名接受姑息性放疗和帕博利珠单抗治疗的恶性胸膜间皮瘤患者的远隔效应
Clin Transl Radiat Oncol. 2021 Jan 1;27:85-88. doi: 10.1016/j.ctro.2020.12.006. eCollection 2021 Mar.
3
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
一线纳武利尤单抗联合伊匹单抗治疗不可切除恶性胸膜间皮瘤(CheckMate 743):一项多中心、随机、开放标签、III 期临床试验。
Lancet. 2021 Jan 30;397(10272):375-386. doi: 10.1016/S0140-6736(20)32714-8. Epub 2021 Jan 21.
4
Mesothelioma Biomarkers: Discovery in Search of Validation.间皮瘤生物标志物:寻求验证的发现
Thorac Surg Clin. 2020 Nov;30(4):395-423. doi: 10.1016/j.thorsurg.2020.08.001. Epub 2020 Sep 14.
5
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.一项比较派姆单抗与单药化疗治疗晚期预处理恶性胸膜间皮瘤的多中心随机 III 期试验:欧洲胸部肿瘤平台(ETOP 9-15)PROMISE-meso 试验。
Ann Oncol. 2020 Dec;31(12):1734-1745. doi: 10.1016/j.annonc.2020.09.009. Epub 2020 Sep 22.
6
Immunotherapy in Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的免疫治疗
Front Oncol. 2020 Feb 21;10:187. doi: 10.3389/fonc.2020.00187. eCollection 2020.
7
Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma.不可切除恶性胸膜间皮瘤中免疫检查点抑制剂的现有证据和未来展望。
J Immunother Cancer. 2020 Feb;8(1). doi: 10.1136/jitc-2019-000461.
8
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies.帕博利珠单抗用于复发性或转移性小细胞肺癌患者接受过两线或更多线既往治疗后的疗效:KEYNOTE-028和KEYNOTE-158研究结果
J Thorac Oncol. 2020 Apr;15(4):618-627. doi: 10.1016/j.jtho.2019.12.109. Epub 2019 Dec 20.
9
Radiation-induced tumor immunity in patients with non-small cell lung cancer.非小细胞肺癌患者的放射诱导肿瘤免疫。
Thorac Cancer. 2019 Jul;10(7):1605-1611. doi: 10.1111/1759-7714.13122. Epub 2019 Jun 22.
10
First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma.姑息性放疗和免疫基因治疗恶性胸膜间皮瘤后首次出现远隔效应
Cureus. 2019 Feb 20;11(2):e4102. doi: 10.7759/cureus.4102.